KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
Scelo, Ghislaine Muller, David C Riboli, Elio Johansson, Mattias Cross, Amanda J Vineis, Paolo Tsilidis, Konstantinos K Brennan, Paul Boeing, Heiner Peeters, Petra H M
Scelo, Ghislaine
Muller, David C
Riboli, Elio
Johansson, Mattias
Cross, Amanda J
Vineis, Paolo
Tsilidis, Konstantinos K
Brennan, Paul
Boeing, Heiner
Peeters, Petra H M
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2018-11-15
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
Translated Title
Published in
Clin Cancer Res 2018; 24(22):5594-5601
Abstract
Renal cell carcinoma (RCC) has the potential for cure with surgery when diagnosed at an early stage. Kidney injury molecule-1 (KIM-1) has been shown to be elevated in the plasma of RCC patients. We aimed to test whether plasma KIM-1 could represent a means of detecting RCC prior to clinical diagnosis.